2024 stock market rally: a final chance for once-in-a-decade bargains?

The UK stock market’s up by double digits this year, but will this momentum continue? And is 2024 a last chance to capitalise on once-in-a-decade bargains?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

A front-view shot of a multi-ethnic family with two children walking down a city street on a cold December night.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Being invested in the British stock market in 2024 has been immensely rewarding, so far. After years of lacklustre performance in the wake of rising inflation, momentum appears to have made a comeback. And, subsequently, the FTSE 100 is up by almost 11% since mid-January. And this figure jumps even higher to 13% when including dividends.

That’s almost double what the UK’s flagship index typically achieves in a whole year. And it’s the rally investors have been patiently waiting for. But what’s actually driving these spectacular gains? And could this surge be just the tip of the iceberg? Let’s take a closer look.

Profiting from a correction

Stock market corrections are a sustained downward slide in prices over many months, or even years. We’ve all had to endure this recently and, needless to say, it’s hardly a pleasant experience. But while the short-term can be quite gloomy, these events create amazing wealth-building opportunities.

Should you invest £1,000 in NIO right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if NIO made the list?

See the 6 stocks

In fact, the downward volatility created incredible bargains for some top-notch businesses – something that my Foolish colleagues have been pointing out over the last 18 months. And for those prudent in their investing choices, the rewards are finally starting to materialise, with the UK’s leading index trading near a new all-time high.

What’s behind the double-digit gains?

While there are many British businesses seeing their share prices move back in the right direction, the FTSE 100 continues to be driven by a small selection. Don’t forget, it’s a market-cap weighted index. And that means firms like AstraZeneca (LSE:AZN), Shell, HSBC Holdings, and Unilever have a massive influence on overall performance.

Created with Highcharts 11.4.3AstraZeneca Plc PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.co.uk

As it turns out, all four of these firms are making a comeback, climbing by 11.4%, 7.8%, 8.9%, and 11.2% respectively, since the start of the year. While some of this growth is undoubtedly from earlier mispricing, investors ought to spend time investigating what other catalysts are at play. Why? Because it might uncover an even bigger opportunity.

Take AstraZeneca for example. This year’s rally has been primarily fuelled by the tremendous success of its cancer drugs. Revenue from this division grew by a staggering 26% to over $5bn (£3.9bn). Consequently, management crushed analyst targets and forecasts and could be on track to continue doing so. After all, other drugs in its portfolio are also beating expectations. In particular, Farxiga (a treatment for diabetes and heart failure) netted almost $1.9bn (£1.5bn) in just three months!

Given these impressive results, management has rolled out its plan to increase the group’s total revenue stream to $80bn (£62.7bn) by 2030. That’s almost double what was achieved in 2023, suggesting that the growth opportunities at AstraZeneca are only getting started.

Balancing opportunity with risk

If AstraZeneca is successful in hitting its 2030 target, then this year’s rally could be set to continue. And since severe stock market corrections are pretty rare, it could be over a decade before we get another opportunity like this. Don’t forget, the last bull market lasted almost 15 years.

However, a lot of things have to go right for AstraZeneca is deliver on its upcoming milestones. The firm has vast financial and intellectual resources. But drug development remains notoriously difficult. And a failure in late-stage clinical trials for a new blockbuster drug could invite considerable volatility in the share price.

Therefore, as exciting as the growth opportunity may be, investors must stay disciplined and aim to keep their portfolios diversified.

Like buying £1 for 31p

This seems ridiculous, but we almost never see shares looking this cheap. Yet this Share Advisor pick has a price/book ratio of 0.31. In plain English, this means that investors effectively get in on a business that holds £1 of assets for every 31p they invest!

Of course, this is the stock market where money is always at risk — these valuations can change and there are no guarantees. But some risks are a LOT more interesting than others, and at The Motley Fool we believe this company is amongst them.

What’s more, it currently boasts a stellar dividend yield of around 10%, and right now it’s possible for investors to jump aboard at near-historic lows. Want to get the name for yourself?

See the full investment case

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

HSBC Holdings is an advertising partner of The Ascent, a Motley Fool company. Zaven Boyrazian has no position in any of the shares mentioned. The Motley Fool UK has recommended AstraZeneca Plc, HSBC Holdings, and Unilever Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Calendar showing the date of 5th April on desk in a house
Investing Articles

Here’s how a £20k ISA could produce £1,580 of passive income in the next year

A Stocks and Shares ISA stuffed with dividend shares can be a lucrative source of passive income. Christopher Ruane explains…

Read more »

Investing Articles

Prediction: 12 months from now, £5,000 invested in Tesla stock could be worth…

Tesla stock has endured a miserable year so far, falling by 29%. Muhammad Cheema takes a look at how it…

Read more »

Investing Articles

See what £10,000 invested in Tesla shares at their mid-December peak is worth today 

As the world absorbs the full scale of Donald Trump's tariffs, Tesla shares are reeling. Investors who bought the stock…

Read more »

Hand flipping wooden cubes for change wording" Panic " to " Calm".
Dividend Shares

2 ‘safe’ LSE dividend stocks to consider as global markets sell off

As global markets experience high levels of volatility due to economic uncertainty, investors are piling into these ‘safe-haven’ dividend stocks.

Read more »

Investing Articles

US stock market rout: an unmissable opportunity for investors?

His tech-heavy portfolio has been smashed by Trump’s tariffs. However, Dr James Fox believes there could be some opportunities in…

Read more »

Investing Articles

After a 13% ‘Trump tariff’ fall, is the Barclays share price too cheap to miss?

Does the Barclays share price fall mean we should all panic and run screaming from the stock market? Nah, of…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

2 investment trusts to consider for a Stocks and Shares ISA

These two investment trusts have a different focus -- but our writer sees both as worth considering, one more for…

Read more »

Investing Articles

Deutsche Bank reiterates Buy rating on 9.6% yielding FTSE 250 stock that was “most shorted in UK”

Our writer investigates why a major broker remains optimistic about a FTSE 250 stock that was once the most shorted…

Read more »